↓ Skip to main content

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

Overview of attention for article published in Lancet Neurology, March 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
14 X users
patent
5 patents
facebook
2 Facebook pages

Citations

dimensions_citation
208 Dimensions

Readers on

mendeley
228 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
Published in
Lancet Neurology, March 2015
DOI 10.1016/s1474-4422(14)70303-5
Pubmed ID
Authors

Ronit M Pressler, Geraldine B Boylan, Neil Marlow, Mats Blennow, Catherine Chiron, J Helen Cross, Linda S de Vries, Boubou Hallberg, Lena Hellström-Westas, Vincent Jullien, Vicki Livingstone, Barry Mangum, Brendan Murphy, Deirdre Murray, Gerard Pons, Janet Rennie, Renate Swarte, Mona C Toet, Sampsa Vanhatalo, Sarah Zohar, for the NEonatal seizure treatment with Medication Off-patent consortium

Abstract

Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. We aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 228 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
United States 2 <1%
Finland 1 <1%
Austria 1 <1%
United Kingdom 1 <1%
India 1 <1%
Unknown 220 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 14%
Student > Ph. D. Student 25 11%
Student > Master 24 11%
Student > Bachelor 24 11%
Professor > Associate Professor 17 7%
Other 61 27%
Unknown 46 20%
Readers by discipline Count As %
Medicine and Dentistry 64 28%
Neuroscience 35 15%
Agricultural and Biological Sciences 19 8%
Nursing and Health Professions 12 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 32 14%
Unknown 57 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#595,104
of 25,461,852 outputs
Outputs from Lancet Neurology
#375
of 4,013 outputs
Outputs of similar age
#7,174
of 274,545 outputs
Outputs of similar age from Lancet Neurology
#6
of 81 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,013 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,545 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.